|
1
|
Oyan B, Engin H and Yalcin S: Generalized
lymphadenopathy: A rare presentation of disseminated prostate
cancer. Med Oncol. 19:177–199. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Makusha LP, Kulon M, Pucar D and Young CR:
Inferior vena cava syndrome on skeletal scintigraphy secondary to
metastatic prostate cancer. World J Nud Med. 19:324–326. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kasimis BS and Spiers AS: Inferior vena
cava obstruction. A complication of prostate cancer. Arch Intern
Med. 139:1056–1057. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Heresi GA, Wang J, Taichman R, Taichman R,
Chirinos JA, Regalado JJ, Lichtstein DM and Rosenblatt JD:
Expression of the chemokine receptor CCR7 in prostate cancer
presenting with generalized lymphadenopathy: Report of a case,
review of the literature, and analysis of chemokine receptor
expression. Urol Oncol. 23:261–267. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karatzas AD, Zachos I, Mitrakas L,
Dimitropoulos K, Samarinas M, Gravas S, Oeconomou A and Tzortzis V:
Generalized lymphadenopathy of prostate adenocarcinoma origin. A
case series. Urology. 91:e3–e4. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krpina K, Markić D, Rahelić D, Ahel J,
Rubinić N and Španjol J: 10-year survival of a patient with
metastatic prostate cancer: Case report and literature review. Arch
Ital Urol Androl. 87:252–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hameed O, Sublett J and Humphrey PA:
Immunohistochemical stains for p63 and alpha-methylacyl-CoA
racemase, versus a cocktail comprising both, in the diagnosis of
prostatic carcinoma: A comparison of the immunohistochemical
staining of 430 foci in radical prostatectomy and needle biopsy
tissues. Am J Surg Pathol. 29:579–587. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Epstein JI, Egevad L, Amin MB, Delahunt B,
Srigley JR and Humphrey PA; Grading Committee, : The 2014
international society of urological pathology (ISUP) consensus
conference on gleason grading of prostatic carcinoma: Definition of
grading patterns and proposal for a new grading system. Am J Surg
Pathol. 40:244–25. 2005. View Article : Google Scholar
|
|
9
|
Chan G and Domes T: Supraclavicular
lymphadenopathy as the initial presentation of metastatic prostate
cancer: A case report and review of literature. Can Urol Assoc J.
7:E433–E435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turkbey B, Basaran C, Boge M,
Karcaaltincaba M and Akata D: Unusual presentation of prostate
cancer with generalized lymphadenopathy and unilateral leg edema.
JBR-BTR. 91:211–213. 2008.PubMed/NCBI
|
|
11
|
Lad M, Sharma A and Patten DK: A
surprising diagnosis: Metastatic prostate cancer causing cervical
lymphadenopathy. BMJ Case Rep. 11:bcr20132016302014. View Article : Google Scholar
|
|
12
|
Hematpour K, Bennett CJ, Rogers D and Head
CS: Supraclavicular lymph node: Incidence of unsuspected metastatic
prostate cancer. Eur Arch Otorhinolaryngol. 263:872–874. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Uemura M, Hirai T, Kanno N, Nishimura K,
Mizutani S, Miyoshi S, Yoshida K and Kawano K: Prostatic carcinoma
presenting as neck lymph node metastases: Report of two cases.
Hinyokika Kiyo. 47:755–758. 2001.(In Japanese). PubMed/NCBI
|
|
14
|
Tan-Shalaby J: Prostate carcinoma
presenting with bulky mediastinal and cervical lymphadenopathy. BMJ
Case Rep. 22:bcr20130086432013. View Article : Google Scholar
|
|
15
|
Kosugi S, Mizumachi S, Kitajima A,
Igarashi T, Hamada T, Kaya H, Kurihara K, Ogasawara K, Sakata H,
Yamamoto M, et al: Prostate cancer with supraclavicular
lymphadenopathy and bulky abdominal tumor. Intern Med.
46:1135–1138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haraoka M, Takamuki M, Toyonaga Y, Tanaka
M, Hanazawa K, Sakamoto Y and Horie S: Prostate cancer of unknown
primary origin with multiple lymph nodes metastasis; a case report.
Nihon Hinyokika Gakkai Zasshi. 105:212–217. 2014.(In Japanese).
PubMed/NCBI
|
|
17
|
Platania M, Bajetta E, Guadalupi V,
Buzzoni R and Colecchia M: Prostate adenocarcinoma presenting with
supraclavicular node enlargement: Report of a case. Tumori.
94:769–771. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin YY, Lin DS, Kang BH and Lin YS: Neck
mass as the first presentation of metastatic prostatic
adenocarcinoma. J Chin Med Assoc. 74:570–573. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de Diego Rodríguez E, del Valle Schaan JI,
Baños JL, García BM, Rodríguez RH, Martín JA, Gómez MA, Edreira AR,
Peña AV, Velázquez MA and Rodríguez AH: Massive lymphatic
involvement secondary to prostatic adenocarcinoma. Actas Urol Esp.
24:836–839. 2000.(In Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garg PK, Jain BK, Dubey IB and Sharma AK:
Generalized lymphadenopathy: Physical examination revisited. Ann
Saudi Med. 33:298–300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang F, Dávila S, Ovalles V, Mejías E,
Rodríguez O and Rodríguez R: Cervical adenopathy presentation of
adenocarcinoma of prostate. Actas Urol Esp. 31:1193–1195. 2007.(In
Spanish). View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimizu K, Nakano S, Okada Y, Nagahama K,
Okubo K and Yasuhara Y: A case of prostate cancer with high levels
of prostate-specific antigen undetected by prostate biopsy.
Hinyokika Kiyo. 65:75–80. 2019.(In Japaese). PubMed/NCBI
|
|
23
|
Wang J, Liu X, Wang Y and Ren G: Current
trend of worsening prognosis of prostate small cell carcinoma: A
population-based study. Cancer Med. 8:6799–6806. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okoye E, Choi EK, Divatia M, Miles BJ,
Ayala AG and Ro JY: De novo large cell neuroendocrine carcinoma of
the prostate gland with pelvic lymph node metastasis: A case report
with review of literature. Int J Clin Exp Pathol. 7:9061–9066.
2014.PubMed/NCBI
|
|
25
|
Lopez-Beltran A, Eble JN and Bostwick DG:
Pleomorphic giant cell carcinoma of the prostate. Arch Pathol Lab
Med. 129:683–685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Biyani CS, Basu S, Bottomley DM and Shah
TK: Prostatic adenocarcinoma masquerading as lymphoma and
presentation with axillary-subclavian vein thrombosis. Urol Oncol.
21:3–6. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yun HD and Ershler WB: Superior vena cava
syndrome as a presentation of metastatic prostate cancer. BMJ Case
Rep. 3:bcr20120064802012. View Article : Google Scholar
|
|
28
|
Hashimoto Y, Kimura G, Tsuboi N and
Akimoto M: A case of prostatic small cell carcinoma. Hinyokika
Kiyo. 46:425–427. 2000.(In Japanese). PubMed/NCBI
|
|
29
|
Tsukino H, Nagano M, Takehara T, Hamasuna
R, Hasui Y and Osada Y: Small cell carcinoma of the prostate: A
case report. Hinyokika Kiyo. 47:113–116. 2001.(In Japanese).
PubMed/NCBI
|
|
30
|
Shun Z, Cheng W, Su-Bo Q, Yu D, Chen W,
Huang-Qi D, Wei-Min X and Hai-Bo S: Large cell neuroendocrine
carcinoma of prostate: A case report. Journal of Shanghai Jiao Tong
University (Medical Science). 40:1562–1570. 2020.
|
|
31
|
Kimura H, Uegaki M, Aoyama T, Kawai J,
Hamano T and Hashimura T: Carboplatin plus irinotecan induced
partial response in a patient with small cell carcinoma of the
prostate; a case report. Hinyokika Kiyo. 60:39–43. 2014.(In
Japanese). PubMed/NCBI
|
|
32
|
Fizazi K, Foulon S, Carles J, Roubaud G,
McDermott R, Fléchon A, Tombal B, Supiot S, Berthold D, Ronchin P,
et al: Abiraterone plus prednisone added to androgen deprivation
therapy and docetaxel in de novo metastatic castration-sensitive
prostate cancer (PEACE-1): A multicentre, open-label, randomised,
phase 3 study with a 2×2 factorial design. Lancet. 399:1695–1707.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Smith MR, Hussain M, Saad F, Fizazi K,
Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B,
Montesa-Pino Á, et al: Darolutamide and survival in metastatic,
hormone-sensitive prostate cancer. N Eng J Med. 386:1132–1142.
2022. View Article : Google Scholar
|
